These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 960851)

  • 1. [Transitional symptoms, adverse effects and incidents in hormone-substitution therapy].
    Kaiser W
    Z Gesamte Inn Med; 1976 May; 31(10):305-11. PubMed ID: 960851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of endocrine diseases in childhood and adolescence. 2. Connatal athyreosis. 3. Diabetes insipidus neurohormonalis].
    Butenandt O
    Fortschr Med; 1983 Sep; 101(34):1497-500. PubMed ID: 6629280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes insipidus in sarcoidosis].
    Fischer B; Müller-Quernheim J; Ferlinz R
    Pneumologie; 1991 Mar; 45(3):100-4. PubMed ID: 2031045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse effects of longtime dihydrotachysterol substitution therapy].
    Kaiser W; Schmidt GA
    Z Gesamte Inn Med; 1973 Apr; 28(8):117-8. PubMed ID: 4197805
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased sensitivity to thyroid hormone replacement therapy followed by hyponatremia and eosinophilia in a patient with long-standing young-onset primary hypothyroidism.
    Fujikawa M; Okamura K; Sato K; Mizokami T; Shiratsuchi M; Fujishima M
    J Endocrinol Invest; 1999 Jun; 22(6):476-80. PubMed ID: 10435859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
    Kauli R; Laron Z
    Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 11. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of diabetes insipidus].
    Quist Paulsen A
    Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1222-3. PubMed ID: 968848
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin) in the treatment of diabetes insipidus in children.
    Némethová V; Lichardus B
    Endokrinologie; 1974 Mar; 63(1):137-41. PubMed ID: 4611759
    [No Abstract]   [Full Text] [Related]  

  • 14. Early diagnosis and treatment reverse clinical features in Hoffmann's syndrome due to hypothyroid myophaty: a case report.
    Ozdag MF; Eroglu E; Ulas UH; Ipekdal I; Odabasi Z; Vural O
    Acta Neurol Belg; 2005 Dec; 105(4):212-3. PubMed ID: 16482871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insufficient water load elimination during administration of 1 (3-mercaptopropionic acid)-8-D-arginine vasopressin (adiuretin) in diabetes insipidus].
    Bittel-Dobrzyńska N
    Pediatr Pol; 1980 Apr; 55(4):441-51. PubMed ID: 7413306
    [No Abstract]   [Full Text] [Related]  

  • 16. Sub-laboratory hypothyroidism and the empirical use of Armour thyroid.
    Gaby AR
    Altern Med Rev; 2004 Jun; 9(2):157-79. PubMed ID: 15253676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium induced nephrogenic diabetes insipidus: changes in plasma vasopressin and angiotensin II.
    Padfield PL; Morton JJ; Lindop G; Timbury GC
    Clin Nephrol; 1975 Jun; 3(6):220-4. PubMed ID: 1139806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone therapies in pregnancy].
    Tommaselli GA; Pellicano M; Guida M; Palomba S; Savarese F; Nola B; Ferrara C; Lapadula C; Nappi C
    Minerva Ginecol; 2002 Apr; 54(2):145-50. PubMed ID: 12032452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.